Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
about
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeAlanine aminotransferase-old biomarker and new concept: a reviewAspartate aminotransferase - risk marker for type-2 diabetes mellitus or red herring?Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicineNon-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Newly diagnosed diabetes mellitus as a risk factor for serious liver diseaseMetabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.Gender difference in the association between aminotransferase levels and hypertension in a Chinese elderly population.The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.Atherogenic dyslipidemia and cardiovascular risk factors in obese childrenAlanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulationAnthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methodsAlanine aminotransferase within reference range is associated with metabolic syndrome in middle-aged and elderly Chinese men and womenThe metabolic syndrome and nonalcoholic fatty liver disease in childrenLong-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysisCholesterol-cholate-butterfat diet offers multi-organ dysfunction in rats.Associations of matrix metalloproteinase (MMP)-8, MMP-9, and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys.Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studiesComplex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies.Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese menGalantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice.Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.Prevalence of metabolic syndrome and related factors in Taiwanese high-tech industry workersAssociation between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.The Framingham risk score and heart disease in nonalcoholic fatty liver disease.Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.Elevation of Serum Aminotransferase Levels and Future Risk of Death from External Causes: A Prospective Cohort Study in KoreaConsumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.Liver enzymes and metabolic syndrome: a large-scale case-control studyRelation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation.Anthropometric Indices in Adults: Which Is the Best Indicator to Identify Alanine Aminotransferase Levels?Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart StudyMitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseMetabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes
P2860
Q26765455-FBAAA048-75D3-4920-BEC4-E00BA86FE183Q26828819-744584EA-679C-42A9-93F2-44DCD90B20A8Q26849784-3FD2E079-4310-4A0E-8941-E3A5225DFFF6Q28086887-B2CCA275-9BE1-4570-85B0-12C128DCBF6FQ30401022-AE915933-5183-4C40-B779-E0F2A3979BC0Q30495922-99A21245-1523-4A64-A6E0-0D2924C6D8E4Q30570152-D6958DA3-CADA-4C03-9F2F-7B466AED4638Q33627245-AD4D149D-053E-4EED-A50A-0827AF5C133EQ33640536-2C2FC06D-28C8-44CF-B508-3455F51B7D18Q33760639-E1B051F6-032A-4317-93E7-35C7F5598803Q34043671-B4CC00E9-D4EA-4B7F-9104-ADB5C1E65D69Q34461856-F6B92F99-D1FB-49DC-8BA8-03B1584134F4Q34592729-871EAE82-9C52-45B6-9F27-8C0181721FAAQ34746071-A028F92D-2EE0-4E2A-9BF5-455A0BDBE3FBQ34773457-24E5D342-AA0B-46E8-B607-21847EF41DF5Q34778237-1D111950-36C0-45E2-B746-96C9F696BCD3Q34804834-F9390504-1DAB-47DE-94BA-8464C9ADB8B3Q34864638-A768CC59-EEB1-4E6E-9012-A675612BC55DQ34911107-68653E42-9961-4838-A22A-5C4B9FAF9717Q35047420-5F36E4F5-BAF9-4806-8D29-09A25C00C0B8Q35063759-7948CCC0-422D-4AF9-B200-3C36DEC194E7Q35122003-704CFE8D-DC21-486D-AE01-F0F597849D71Q35125070-82166BE0-4538-4346-B126-4047F4725234Q35136695-0B020C54-FFF5-4AED-A248-1B69BE7F0858Q35159698-260004C9-BA31-408F-8A17-930FAFB8F536Q35188348-26219BAD-ADF6-4AAB-81B6-16273E99EC57Q35687497-6A87CB62-22D2-4E4D-B848-A9C1321F88D3Q35733564-230B059F-0A26-4E01-A990-A0246D700B9DQ35833048-6CB178D6-0E15-49EF-888E-271C15336407Q35946523-B4C63A65-723B-431C-8204-22ABDDFA0419Q36144444-DC254B41-9086-48B5-BE0A-C7CFF6893297Q36240154-88B3C762-4C47-4939-8ECB-B035280F5914Q36295250-8534D0A4-E366-4535-A00B-40AC42E780B9Q36413611-AAE7DD3F-A4BC-481F-B1E1-C4B0A663A8D6Q36514049-D587DE57-F05A-48A6-B58D-87F27ED2BE99Q36633948-334677D1-A660-451C-BE04-3081A01E26E1Q36672592-D48E9B76-EF9E-4E9B-A698-8D278E127F6FQ36740555-2F693AD6-336F-43FD-B9F7-BEF58583FAFAQ36921610-4BA6E9D6-42A4-4446-87F3-4717E6BEA5CCQ36935538-A13DDD4C-1BBF-4C4C-8BE8-F593ECBBC524
P2860
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@ast
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@en
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@nl
type
label
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@ast
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@en
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@nl
prefLabel
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@ast
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@en
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@nl
P2093
P2860
P50
P1433
P1476
Aminotransferase levels and 20 ...... s, and cardiovascular disease.
@en
P2093
Caroline S Fox
R Curtis Ellison
Ralph B D'Agostino
P2860
P304
1935-44, 1944.e1
P356
10.1053/J.GASTRO.2008.09.018
P407
P577
2008-09-20T00:00:00Z